TG Therapeutics Inc
NASDAQ:TGTX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
13.02
35.09
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
TG Therapeutics Inc
Wall Street
Price Targets
TGTX Price Targets Summary
TG Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
TGTX
is 41.57 USD
with a low forecast of 9.09 USD and a high forecast of 57.75 USD.
TGTX Last Price Targets
TG Therapeutics Inc
The latest public price target was made on Nov 5, 2024 by
Edward White
from
H.C. Wainwright
,
who expects
TGTX
stock to
rise by 71%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
|
Edward White
H.C. Wainwright
|
55
USD
Upside 71% |
1 month ago
Nov 5, 2024
|
TG Therapeutics (TGTX) PT Raised to $55 at H.C. Wainwright
StreetInsider
|
Corinne Jenkins
Goldman Sachs
|
20
USD
Downside 38% |
4 months ago
Aug 6, 2024
|
TG Therapeutics price target raised to $20 from $18 at Goldman Sachs
TheFly
|
|
Edward White
H.C. Wainwright
|
49
USD
Upside 52% |
7 months ago
May 3, 2024
|
TG Therapeutics (TGTX) PT Raised to $49 at H.C. Wainwright
StreetInsider
|
|
Unknown Analyst
Cantor Fitzgerald
|
24
USD
Downside 25% |
1 year ago
Feb 7, 2023
|
Cantor Fitzgerald Maintains Overweight on TG Therapeutics, Raises Price Target to $24
Benzinga
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is TGTX's stock price target?
Price Target
41.57
USD
According to Wall Street analysts, the average 1-year price target for
TGTX
is 41.57 USD
with a low forecast of 9.09 USD and a high forecast of 57.75 USD.
What is TG Therapeutics Inc's Revenue forecast?
Projected CAGR
48%
For the last 8 years the
compound annual growth rate for
TG Therapeutics Inc's revenue is
151%.
The projected
CAGR
for the next 4 years is
48%.
What is TG Therapeutics Inc's Operating Income forecast?
Projected CAGR
132%
The
compound annual growth rate
of TG Therapeutics Inc's operating income for the next 4 years is
132%.
What is TG Therapeutics Inc's Net Income forecast?
Projected CAGR
139%
The
compound annual growth rate
of TG Therapeutics Inc's net income for the next 4 years is
139%.
You don't have any saved screeners yet
